Grupo de Hemato-Oncologia Molecular, Coordenação de Pesquisa, Instituto Nacional de Câncer, Rio de Janeiro 20230-130, CEP, Brazil.
Programa de Pós-Graduação Stricto Sensu em Oncologia, Instituto Nacional de Câncer, Rio de Janeiro 20231-050, CEP, Brazil.
Int J Mol Sci. 2023 Feb 2;24(3):2942. doi: 10.3390/ijms24032942.
Classically, osteopontin (OPN) has been described as a secreted glycophosprotein. Indeed, most data concerning its physiological and pathological roles are mainly related to the secreted OPN (sOPN). However, there are several instances in which intracellular OPN (iOPN) has been described, presenting some specific roles in distinct experimental models, such as in the immune system, cancer cells, and neurological disorders. We herein aimed to highlight and discuss some of these secreted and intracellular roles of OPN and their putative clinical and biological impacts. Moreover, by consolidating data from the OPN protein database, we also analyzed the occurrence of signal peptide (SP) sequences and putative subcellular localization, especially concerning currently known OPN splicing variants (OPN-SV). Comprehending the roles of OPN in its distinct cellular and tissue environments may provide data regarding the additional applications of this protein as biomarkers and targets for therapeutic purposes, besides further describing its pleiotropic roles.
经典地,骨桥蛋白 (OPN) 被描述为一种分泌型糖基化蛋白。事实上,关于其生理和病理作用的大多数数据主要与分泌型 OPN(sOPN)有关。然而,有几种情况下描述了细胞内 OPN(iOPN),在不同的实验模型中呈现出一些特定的作用,如免疫系统、癌细胞和神经紊乱。在此,我们旨在强调和讨论 OPN 的一些分泌和细胞内作用及其潜在的临床和生物学影响。此外,通过整合 OPN 蛋白数据库中的数据,我们还分析了信号肽(SP)序列和可能的亚细胞定位的发生情况,特别是目前已知的 OPN 剪接变异体(OPN-SV)。理解 OPN 在其不同的细胞和组织环境中的作用可能为该蛋白作为生物标志物和治疗靶点的额外应用提供数据,此外还进一步描述了其多效性作用。